Headlands Technologies LLC Makes New Investment in Bruker Co. (NASDAQ:BRKR)

Headlands Technologies LLC acquired a new position in Bruker Co. (NASDAQ:BRKR) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,103 shares of the medical research company’s stock, valued at approximately $326,000.

Several other institutional investors have also added to or reduced their stakes in the stock. Malaga Cove Capital LLC increased its stake in shares of Bruker by 16.5% in the 2nd quarter. Malaga Cove Capital LLC now owns 8,335 shares of the medical research company’s stock worth $532,000 after acquiring an additional 1,182 shares in the last quarter. Quest Partners LLC increased its stake in shares of Bruker by 133.8% in the 2nd quarter. Quest Partners LLC now owns 3,343 shares of the medical research company’s stock worth $213,000 after acquiring an additional 1,913 shares in the last quarter. Candriam S.C.A. increased its stake in shares of Bruker by 218.3% in the 2nd quarter. Candriam S.C.A. now owns 321,205 shares of the medical research company’s stock worth $20,495,000 after acquiring an additional 220,278 shares in the last quarter. Arizona State Retirement System increased its stake in shares of Bruker by 7.0% in the 2nd quarter. Arizona State Retirement System now owns 26,445 shares of the medical research company’s stock worth $1,687,000 after acquiring an additional 1,720 shares in the last quarter. Finally, Larson Financial Group LLC increased its stake in shares of Bruker by 49.0% in the 2nd quarter. Larson Financial Group LLC now owns 2,823 shares of the medical research company’s stock worth $180,000 after acquiring an additional 929 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on BRKR shares. Wells Fargo & Company assumed coverage on shares of Bruker in a report on Tuesday, August 27th. They set an “overweight” rating and a $78.00 price target on the stock. Citigroup decreased their target price on shares of Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, July 10th. The Goldman Sachs Group decreased their target price on shares of Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research note on Tuesday, July 9th. Stifel Nicolaus reduced their price objective on shares of Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a research report on Monday, May 20th. Finally, TD Cowen reduced their price objective on shares of Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a research report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $81.40.

Bruker Price Performance

Bruker stock opened at $65.66 on Friday. The company has a market cap of $9.94 billion, a price-to-earnings ratio of 23.88, a PEG ratio of 2.31 and a beta of 1.18. The firm’s fifty day moving average is $64.17 and its 200 day moving average is $73.59. The company has a quick ratio of 0.75, a current ratio of 1.65 and a debt-to-equity ratio of 1.18. Bruker Co. has a 52-week low of $53.79 and a 52-week high of $94.86.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.52. The company had revenue of $800.70 million for the quarter, compared to the consensus estimate of $799.44 million. Bruker had a net margin of 11.29% and a return on equity of 24.92%. Bruker’s revenue was up 17.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.50 earnings per share. Sell-side analysts forecast that Bruker Co. will post 2.61 EPS for the current fiscal year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 16th. Investors of record on Monday, September 2nd will be paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend is Friday, August 30th. Bruker’s payout ratio is 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.